Craig Johnson A.'s most recent trade in Aurinia Pharmaceuticals Inc was a trade of 37,485 Director Stock Option (right to buy) done . Disclosure was reported to the exchange on May 16, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aurinia Pharmaceuticals Inc | Craig A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2025 | 37,485 | 37,485 | - | - | Director Stock Option (right to buy) | |
| Heron Therapeutics Inc | Craig A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 35,900 | 35,900 | - | - | Stock Option (Right to Buy) | |
| Heron Therapeutics Inc | Craig A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 17,950 | 83,770 (0%) | 0% | 0 | Common Stock | |
| Heron Therapeutics Inc | Craig A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2025 | 35,900 | 35,900 | - | - | Stock Option (Right to Buy) | |
| Heron Therapeutics Inc | Craig A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2025 | 17,950 | 83,770 (0%) | 0% | 0 | Common Stock | |
| Aurinia Pharmaceuticals Inc | Craig A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2024 | 31,688 | 31,688 | - | - | Director Stock Option (right to buy) | |
| Aurinia Pharmaceuticals Inc | Craig A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2024 | 20,631 | 20,631 (0%) | 0% | 0 | Common Shares | |
| Heron Therapeutics Inc | Craig A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2024 | 83,685 | 83,685 | - | - | Stock Option (Right to Buy) | |
| Heron Therapeutics Inc | Craig Johnson A. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2024 | 13,948 | 65,820 (0%) | 0% | 0 | Common Stock | |
| Mirati Therapeutics Inc | Craig A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 7,520 | 7,520 | - | - | Non Qualified Stock Option (right to buy) | |
| Mirati Therapeutics Inc | Craig A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 4,444 | 10,465 (0%) | 0% | 0 | Common Stock | |
| Heron Therapeutics Inc | Craig A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2022 | 77,160 | 77,160 | - | - | Stock Option (Right to Buy) | |
| Heron Therapeutics Inc | Craig A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2022 | 38,580 | 51,872 (0%) | 0% | 0 | Common Stock | |
| Mirati Therapeutics Inc | Craig A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 3,688 | 3,688 | - | - | Non Qualified Stock Option (right to buy) | |
| Mirati Therapeutics Inc | Craig A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 2,546 | 6,021 (0%) | 0% | 0 | Common Stock | |
| Heron Therapeutics Inc | Craig A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2021 | 20,903 | 20,903 | - | - | Stock Option (Right to Buy) | |
| Heron Therapeutics Inc | Craig A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2021 | 10,452 | 13,292 (0%) | 0% | 0 | Common Stock | |
| Heron Therapeutics Inc | Craig A. Johnson | Director | Sale of securities on an exchange or to another person at price $ 9.73 per share. | 21 Dec 2021 | 250 | 2,840 (0%) | 0% | 9.7 | 2,432 | Common Stock |
| Heron Therapeutics Inc | Craig A. Johnson | Director | Sale of securities on an exchange or to another person at price $ 12.30 per share. | 21 Sep 2021 | 250 | 3,090 (0%) | 0% | 12.3 | 3,074 | Common Stock |
| Heron Therapeutics Inc | Craig A. Johnson | Director | Sale of securities on an exchange or to another person at price $ 15.20 per share. | 21 Jun 2021 | 250 | 3,340 (0%) | 0% | 15.2 | 3,801 | Common Stock |
| Heron Therapeutics Inc | Craig A. Johnson | Director | Sale of securities on an exchange or to another person at price $ 17.22 per share. | 06 Apr 2021 | 250 | 3,590 (0%) | 0% | 17.2 | 4,305 | Common Stock |
| Mirati Therapeutics Inc | Craig A. Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.54 per share. | 21 Jan 2021 | 15,000 | 18,475 (0%) | 0% | 20.5 | 308,100 | Common Stock |
| Mirati Therapeutics Inc | Craig A. Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jan 2021 | 15,000 | 0 | - | - | Non Qualified Stock Option (right to buy) | |
| Mirati Therapeutics Inc | Craig A. Johnson | Director | Sale of securities on an exchange or to another person at price $ 211.94 per share. | 21 Jan 2021 | 4,562 | 7,225 (0%) | 0% | 211.9 | 966,852 | Common Stock |
| Mirati Therapeutics Inc | Craig A. Johnson | Director | Sale of securities on an exchange or to another person at price $ 210.01 per share. | 21 Jan 2021 | 3,505 | 14,970 (0%) | 0% | 210.0 | 736,070 | Common Stock |
| Mirati Therapeutics Inc | Craig A. Johnson | Director | Sale of securities on an exchange or to another person at price $ 212.97 per share. | 21 Jan 2021 | 3,372 | 3,853 (0%) | 0% | 213.0 | 718,151 | Common Stock |
| Mirati Therapeutics Inc | Craig A. Johnson | Director | Sale of securities on an exchange or to another person at price $ 210.81 per share. | 21 Jan 2021 | 3,183 | 11,787 (0%) | 0% | 210.8 | 671,004 | Common Stock |
| Mirati Therapeutics Inc | Craig A. Johnson | Director | Sale of securities on an exchange or to another person at price $ 214.75 per share. | 21 Jan 2021 | 334 | 3,475 (0%) | 0% | 214.8 | 71,728 | Common Stock |
| Mirati Therapeutics Inc | Craig A. Johnson | Director | Sale of securities on an exchange or to another person at price $ 213.61 per share. | 21 Jan 2021 | 44 | 3,809 (0%) | 0% | 213.6 | 9,399 | Common Stock |
| Mirati Therapeutics Inc | Craig A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 2,155 | 2,155 | - | - | Non Qualified Stock Option (right to buy) | |
| Mirati Therapeutics Inc | Craig A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 1,475 | 3,475 (0%) | 0% | 0 | Common Stock | |
| Heron Therapeutics Inc | Craig A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2020 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Heron Therapeutics Inc | Craig A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2020 | 3,000 | 3,840 (0%) | 0% | 0 | Common Stock |